Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized Phase 2 Trial of Lactobacillus plantarum P 17630 versus Miconazole (Daktarin) in Vulvovaginal Candidiasis
2018-003095-12Phase 2Completed
- Sponsor
- Proge Farm
- Start
- Jun 2019
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of lactobacillus plantarum P 17630 in vulvovaginal candidiasis (VVC) (2 arms), sponsored by Proge Farm. Primary endpoint: Clinical non-inferiority of Lactobacillus plantarum P 17630 vs miconazole. Started Jun 2019; status: completed.
02
Drugs
lactobacillus plantarum P 17630
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on 2018-003095-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003095-12.